Clinigen Group plc is a global pharmaceutical and services company with a unique combination of businesses focused on providing ethical access to medicines. Its mission is to deliver the right medicine to the right patient at the right time through three areas of global medicine supply; clinical trial, unlicensed and licensed medicines. The Group has sites in North America, Europe, Africa and Asia Pacific. Clinigen are the global leader in the design, implementation and management of Managed Access Programs (Early Access, Compassionate Use) having run over 250 programs for some of the most innovative medicines over the last 30 years.
For more information, please visit www.clinigengroup.com
The World Orphan Drug Congress provides you with a one stop progressive scientific and strategic solution to the orphan drugs industry.